Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “First Line Chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04363801
What this trial is testing

DKN-01 in Combination With Tislelizumab ± Chemotherapy in Patients With Gastric or Gastroesophageal Cancer

Who this might be right for
Gastric CancerGastric AdenocarcinomaGastroEsophageal Cancer
Leap Therapeutics, Inc. 247
Early research (Phase 1)Looking for participantsNCT07060014
What this trial is testing

NALIRIFOX (Nal-IRI Plus 5-FU/LV Plus Oxaliplatin) as First-Line Treatment for Patients With Advanced Small Intestine and Appendiceal Cancers

Who this might be right for
Advanced Small Intestine CancerAppendiceal Cancers
The Methodist Hospital Research Institute 22
Post-approval studies (Phase 4)Not Yet RecruitingNCT07446465
What this trial is testing

FOLFOX Chemotherapy Combined With Fruquintinib and Serplulimab as First-Line Conversion Therapy for Initially Unresectable pMMR/MSS Colorectal Cancer

Who this might be right for
Colorectal Cancer (Locally Advanced or Metastatic)Colorectal Cancer Microsatellite Stable (MSS)
Ye Xu 42
Testing effectiveness (Phase 2)Study completedNCT01585987
What this trial is testing

An Efficacy Study in Gastric and Gastroesophageal Junction Cancer Comparing Ipilimumab Versus Standard of Care Immediately Following First Line Chemotherapy

Who this might be right for
Locally Advanced (Unresectable) or Metastatic Adenocarcinoma of the Gastric and Gastro-esophageal Junction
Bristol-Myers Squibb 143
Testing effectiveness (Phase 2)Ended earlyNCT00850577
What this trial is testing

Ph II of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Treatment of Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Bristol-Myers Squibb 255
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07124884
What this trial is testing

5-fluorouracil Plus Panitumumab (Anti-EGFR) and Sotorasib (KRAS G12C Inhibitor) in First-line Treatment of Patients Non-eligible for a Doublet/Triplet Chemotherapy With Advanced Unresectab

Who this might be right for
Colorectal CarcinomaKRAS G12C MutationUnresectable Colorectal Cancer
Federation Francophone de Cancerologie Digestive 300
Large-scale testing (Phase 3)UnknownNCT05627752
What this trial is testing

Docetaxel Alone or in Combination With Enzalutamide for mCRPC Previously Treated With Abiraterone at mHSPC Stage

Who this might be right for
Prostate CancerCastrate Resistant Prostate Cancer
Zhongnan Hospital 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07083375
What this trial is testing

A Phase II Study of QL1706 With Anti-angiogenesis Therapy and Chemotherapy in Extensive-stage Small Cell Lung Cancer.

Who this might be right for
Extensive Small Cell Lung Cancer
Zhijie Wang 56
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07538271
What this trial is testing

Benmelstobart, Anlotinib, Chemotherapy and Thoracic Radiotherapy for People With Extensive-stage Small Cell Lung Cancer

Who this might be right for
SCLC, Extensive Stage
Yayi He 33
Testing effectiveness (Phase 2)UnknownNCT00764972
What this trial is testing

Phase IB/II Trial Combining Vinorelbine With Sorafenib as First-Line Treatment in Patients With Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
McGill University 36
Testing effectiveness (Phase 2)Study completedNCT02684461
What this trial is testing

Phase II Trial of Sequential Consolidation With Pembrolizumab Followed by Nab-paclitaxel

Who this might be right for
Non Small Cell Lung Cancer
UNC Lineberger Comprehensive Cancer Center 20
Testing effectiveness (Phase 2)UnknownNCT02262897
What this trial is testing

The Efficacy and Safety of Nab-paclitaxel in Pretreated Patients With Extensive Disease of Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Tongji University 40
Large-scale testing (Phase 3)Study completedNCT02114359
What this trial is testing

Chemotherapy Options for the First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Seoul National University Hospital 111
Not applicableStudy completedNCT03532711
What this trial is testing

Potential Predictive Biomarkers in Patients Undergoing First-line Chemotherapy for Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal CancerChemotherapy EffectBiomarker
Fudan University 264
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05979220
What this trial is testing

Study of Dalpiciclib Combined With Letrozole in the Maintenance Treatment of HR Positive and HER2 Negative Metastatic Breast Cancer After First-line Chemotherapy

Who this might be right for
Breast Cancer
Shuangyue Liu 178
Large-scale testing (Phase 3)Active Not RecruitingNCT06591520
What this trial is testing

AK112 Combined With Chemotherapy Versus Durvalumab Combined With Chemotherapy in Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
Akeso 682
Not applicableUnknownNCT02597868
What this trial is testing

A Multicenter, Randomized Clinical Trail Evaluate Effectiveness and Security of Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen After the 1st-line Chemotherapy With Capecitabine Combine Regimen in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer(Overstep)

Who this might be right for
Breast Cancer
Zhejiang Cancer Hospital 132
Large-scale testing (Phase 3)Study completedNCT01950182
What this trial is testing

Trastuzumab Combined With Chemotherapy or Endocrine Therapy to Treat Metastatic Luminal B2 Breast Cancer

Who this might be right for
Breast Cancer
Sun Yat-sen University 392
Testing effectiveness (Phase 2)Study completedNCT00191815
What this trial is testing

Combination Chemotherapy for Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Eli Lilly and Company 70
Large-scale testing (Phase 3)Not Yet RecruitingNCT05976568
What this trial is testing

QL1706 in Combination With Bevacizumab and/or Chemotherapy as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Qilu Pharmaceutical Co., Ltd. 668
Next Page